“Welcoming Back the World: Striving for Innovation, Quality, Compassion, and Collegiality”
July 8-12, 2023
The Palais des congrès
Montréal, QC Canada
Late Breaking Abstract submissions for the AHNS 11th International Conference on Head and Neck Cancer are now closed.
All submitters will be notified of their abstract acceptance status via email in late April 2023.
The Scientific Program Service and Scientific Review Committee will be responsible for selecting oral and poster presentations. Oral presentations will be presented throughout the main scientific session and a short video may be incorporated into an oral podium presentation. Accepted abstracts may be published in the Final Program, on the AHNS website and on the JAMA Otolaryngology – Head & Neck Surgery website.
- You may not submit abstracts/data or updated versions of abstracts/data that were already submitted for the initial Call For Abstracts for the AHNS 11th International Conference on Head and Neck Cancer
- No Previously Published/Presented Submissions (Encore Abstracts): The abstract submitted must present original work that has not and will not be presented prior to the AHNS 11th International Conference on Head and Neck Cancer.
- No Previously Published Submissions/No Submissions Under Consideration For Publication: The abstract submitted must present original work that has not and will not be published or presented prior to the AHNS 11th International Conference on Head and Neck Cancer, and is not currently under review for publication except by permission from the AHNS Program Chair. The exception to this rule is that a manuscript may be submitted to JAMA Otolaryngology – Head & Neck Surgery for special meeting related consideration only after the abstract has been accepted by AHNS for presentation. Manuscripts may not be submitted to any journals for consideration until after AHNS abstract acceptance notification. If the manuscript has been submitted to any journal prior to AHNS abstract acceptance notifications, the Abstract Submitter, Presenter and Senior Author will forfeit the privilege to submit, present, or be listed as an author on abstracts for the 2024 and 2025 AHNS Annual Meetings.
- Trials in Progress and Case Reports may be submitted
- Abstract submissions are limited to 500 words or less
- Images are allowed with abstract submissions. Images must be no larger than 1MB in file size, and no larger than 900 pixels wide by 900 pixels high
- No reference to the authors or the institution should appear within the body of the abstract or in the abstract title
- Abstracts can be edited until the submission site closes. After the submission site closes and the abstracts go into review, the content of the abstracts may not be edited in any way. Please make sure to proof read and double check your abstracts before submission. In addition, AHNS cannot update the content/text of your abstract to include new/updated data after acceptance notifications, although you will be allowed to include these updated findings in your actual presentation.
Authors are asked to choose the topic that best matches the content of their abstract:
- Cancer Biology
- Education/Care Delivery
- Endocrine Surgery
- Functional Outcomes/Quality
- Hypopharynx/Larynx
- Imaging and Screening
- Immunotherapy/Systemic Therapy
- Nasopharynx/Paranasal Sinus/Skull Base
- Oral Cavity
- Oropharynx/HPV Related Disease
- Radiation/Adjuvant Treatment
- Reconstruction/Microvascular Surgery
- Salivary Gland
- Skin Cancers
AHNS Policy on Owner/Employee of Ineligible Companies
The ACCME states “the owners and employees of ineligible companies are considered to have unresolvable financial relationships and must be excluded from participating as planners or faculty, and must not be allowed to influence or control any aspect of the planning, delivery, or evaluation of accredited continuing education, except in the limited circumstances outlined in Standard 3.2.” Therefore, AHNS declares that no employees/owners of an ineligible company may present in AHNS CME accredited sessions.
Click here to view the ACCME’s definition of ineligible company, owner and employee.
Please contact [email protected] with any questions regarding AHNS Policy on Owner/Employee of Ineligible Companies.
AWARDS
Authors are invited to compete for one of the following awards. Only abstracts selected for Podium Presentation will be eligible for awards.
- Robert Maxwell Byers Award in the amount of $1,000 US for the best clinical research paper submitted to the meeting
- Randal Weber, MD Award for Quality, Safety and Value in Head and Neck Oncology in the amount of $1000 for the best paper submitted to the meeting in these areas of academic/clinical interest
- Best Resident Basic Science Research Paper in the amount of $500 US. Only residents in training can compete for this award and must attest that he/she performed at least 80% of the work
- Best Resident Clinical Paper in the amount of $500 US. Only residents in training can compete for this award and must attest that he/she performed at least 80% of the work
- Best Prevention and Early Detection Papers in the amount of $500 US for first place and $250 for second place
To be considered for the awards noted above, you must submit a completed manuscript to the AHNS Office by Friday, May 12, 2023 to be eligible. Only previously unpublished manuscripts will be considered for awards. More details on manuscript submission for awards consideration will be sent out with Podium acceptance notifications.
(Please Note: Submitting a manuscript to AHNS for award eligibility is unrelated to submitting a manuscript to the AHNS-affilitated journal. Please see manuscript instructions for the journal below.)
MANUSCRIPT SUBMISSIONS TO THE AHNS-AFFILIATED JOURNAL
JAMA OTOLARYNGOLOGY – HEAD & NECK SURGERY ARE ENCOURAGED
All accepted abstract submissions are encouraged to submit a manuscript to the AHNS-affiliated journal, JAMA Otolaryngology – Head & Neck Surgery, via the journal’s web-based manuscript submission system (see below).
To be considered for inclusion in the journal’s AHNS Theme Issue, the manuscript must be submitted between April 1, 2023 – August 1, 2023. All papers submitted to the journal undergo thorough peer review and editorial decisions for acceptance for publication are based on the quality the manuscripts and the editorial priorities of the journal. Papers received by these deadlines will have the most favorable chances for success.
JAMA Otolaryngology – Head & Neck Surgery papers can be submitted at:
http://manuscripts.jamaoto.com/cgi-bin/main.plex
All papers must be complete submissions according to the Journal’s Instructions for Authors.
Instructions for JAMA Otolaryngology – Head & Neck Surgery are available at:
http://manuscripts.jamaoto.com/cgi-bin/main.plex?form_type=display_auth_instructions
Important: Authors should also click on the following link to view a 2-minute video with additional instructions
https://youtu.be/Qo_hFJ4W2J4
PASSPORT ADVISORY
Please note: While Canada does not enforce a six-month rule of passport validity, we strongly recommend that your passport is valid for at least six months prior to your entry into Canada. Having a passport that is valid for six months or less when entering Canada could create potential problems.
If you have any questions, please contact the AHNS office:
Email: [email protected] • Phone: 310-437-0559 (ext. 118) • FAX: 310-437-0585